De-escalation of DAPT—A Potential Strategy for Treating Ticagrelor-Related Dyspnea?

Tobias Geisler

doi:10.1055/a-2420-0381

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2024; 124(12): 1162-1163
DOI: 10.1055/a-2420-0381

Invited Editorial Focus

De-escalation of DAPT—A Potential Strategy for Treating Ticagrelor-Related Dyspnea?

Tobias Geisler

¹Department of Cardiology and Angiology, Eberhard Karls University Tübingen Faculty of Medicine, Tubingen, Baden-Württemberg, Germany

› Author Affiliations

Abstract

Full Text

References

References
1 Cattaneo M, Faioni EM. Why does ticagrelor induce dyspnea?. Thromb Haemost 2012; 108 (06) 1031-1036
2 Cattaneo M, Schulz R, Nylander S. Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance. J Am Coll Cardiol 2014; 63 (23) 2503-2509
3 Storey RF, Becker RC, Harrington RA. et al. Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes. Eur Heart J 2011; 32 (23) 2945-2953
4 Angiolillo DJ, Cao D, Sartori S. et al. Dyspnea-related ticagrelor discontinuation after percutaneous coronary intervention. JACC Cardiovasc Interv 2023; 16 (20) 2514-2524
5 Kim SH, Shin S, Choo EH. et al; TALOS-AMI investigators. Clinical impact of dyspnea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction. Thromb Haemost 2024; 124 (12) 1152-1161
6 Ge Z, Kan J, Gao X. et al; ULTIMATE-DAPT investigators. Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial. Lancet 2024; 403 (10439): 1866-1878
7 Kim BK, Hong SJ, Cho YH. et al; TICO Investigators. Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial. JAMA 2020; 323 (23) 2407-2416
8 Kang J, Rizas KD, Park KW. et al. Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis. Eur Heart J 2023; 44 (15) 1360-1370
9 Gimbel M, Qaderdan K, Willemsen L. et al. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial. Lancet 2020; 395 (10233): 1374-1381
10 Gorog DA, Jeyalan V, Markides RIL, Navarese EP, Jeong YH, Farag M. Comparison of de-escalation of DAPT intensity or duration in East Asian and Western patients with ACS undergoing PCI: a systematic review and meta-analysis. Thromb Haemost 2023; 123 (08) 773-792
11 Kim HK, Tantry US, Smith Jr SC. et al. The East Asian Paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease. Thromb Haemost 2021; 121 (04) 422-432